Article info

other Versions

PDF
Systematic review
Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues

Authors

  1. Correspondence to Phyllis Wolff-McDonagh
    Diabetes and Endocrinology Center of Suffolk, 285 Sills Road, East Patchogue, NY 11772 USA; pwolffnp{at}optonline.net
View Full Text

Citation

Wolff-McDonagh P
Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues

Publication history

  • Published online 9 December 2010.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.